Daiwa Securities Group
ALDR

Daiwa Securities Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Daiwa Securities Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-533
Closed -$10K – 1277
2019
Q3 		$10K Buy
533
+25
+5% +$286 ﹤0.01% 1036
2019
Q2 		$6K Hold
508
– – ﹤0.01% 1094
2019
Q1 		$7K Buy
508
+134
+36% +$1.74K ﹤0.01% 1063
2018
Q4 		$4K Hold
374
– – ﹤0.01% 1083
2018
Q3 		$6K Hold
374
– – ﹤0.01% 1078
2018
Q2 		$6K Hold
374
– – ﹤0.01% 1092
2018
Q1 		$5K Buy
+374
New +$5.41K ﹤0.01% 1083

Daiwa Securities Group's ALDR Position: Q4 2019 in Review

Daiwa Securities Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 533 shares — an estimated $10K sold.

Daiwa Securities Group first reported a position in ALDR in Q1 2018 and held it in 7 quarters. The position peaked at $10K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Daiwa Securities Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 533 Alder Biopharmaceuticals shares in Q4 2019, an estimated $10K.
  • Daiwa Securities Group first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Alder Biopharmaceuticals position peaked at $10K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.